37. Rodrigo F.G.M. et al. Outcomes of very-low-birth-weight infants exposed to maternal clinical chorioamnionitis: A multicentre study // Neonatology. 2014. Vol. 106, № 3. P. 229–234.
38. Klinger G. et al. Epidemiology and risk factors for early onset sepsis among very-low-birthweight infants // Am. J. Obstet. Gynecol. Mosby, Inc., 2009. Vol. 201, № 1. P. 38.e1-38.e6.
39. Singh M., Deorari A.K. Pneumonias in newborn babies // Indian J Pediatr. 1995. Vol. 62, № 3. P. 293–306.
40. Mårdh PA, Johansson PJ S.N. Intrauterine Lung Infection with Chlamydia Trachomatis in a Premature Infant // Acta Pædiatrica. 1984. Vol. 73, № 4. P. 569–572.
41. Боконбаева С. Д., Нуржанова С. Т. К.А.А. Сравнительный анализ клинического течения врожденных и неонатальных пневмоний // Здоровье матери и ребенка. 2015. Vol. 1. P. 6–10.
42. Hedstrom A.B. et al. Performance of the Silverman Andersen Respiratory Severity Score in predicting PCO2 and respiratory support in newborns: A prospective cohort study // J. Perinatol. Springer US, 2018. Vol. 38, № 5. P. 505–511.
43. Setty S.G., Batra M., Hedstrom A.B. The Silverman Andersen respiratory severity score can be simplified and still predicts increased neonatal respiratory support // Acta Paediatr. Int. J. Paediatr. 2020. Vol. 109, № 6. P. 1273–1275.
44. Sarkar S. et al. A study of the role of multiple site blood cultures in the evaluation of neonatal sepsis // J. Perinatol. 2006. Vol. 26, № 1. P. 18–22.
45. Polin R.A. et al. Management of Neonates with Suspected or Proven Early-Onset Bacterial Sepsis // Pediatrics. 2012. Vol. 129, № 5. P. 1006–1015.
46. Çelik H.T. et al. Efficacy of new leukocyte parameters versus serum C-reactive protein, procalcitonin, and interleukin-6 in the diagnosis of neonatal sepsis // Pediatr. Int. 2016. Vol. 58, № 2. P. 119–125.
47. Hornik CP, Benjamin DK, Becker KC, Benjamin DK Jr, Li J, Clark RH et al. Use of the complete blood cell count in early-onset neonatal sepsis. // Pediatr Infect Dis J. 2012. Vol. 31, № 8. P. 799-802.
48. Murphy K., Weiner J. Use of leukocyte counts in evaluation of early-onset neonatal sepsis // Pediatr. Infect. Dis. J. 2012. Vol. 31, № 1. P. 16–19.
49. Newman T.B. et al. Combining immature and total neutrophil counts to predict early onset sepsis in term and late preterm newborns: Use of the I/T2 // Pediatr. Infect. Dis. J. 2014. Vol. 33, № 8. P. 798–802.
50. Makkar M. et al. Performance evaluation of hematologic scoring system in early diagnosis of neonatal sepsis // J. Clin. Neonatol. 2013. Vol. 2, № 1. P. 25.
51. Saboohi E. et al. Immature to total neutrophil ratio as an early indicator of early neonatal sepsis // Pakistan J. Med. Sci. 2019. Vol. 35, № 1. P. 241–246.
52. Berardi A. et al. Should we give antibiotics to neonates with mild non-progressive symptoms? A comparison of serial clinical observation and the neonatal sepsis risk calculator // Front. Pediatr. 2022. Vol. 10.
53. Hedegaard S.S., Wisborg K., Hvas A.M. Diagnostic utility of biomarkers for neonatal sepsis - a systematic review // Infect. Dis. (Auckl). 2015. Vol. 47, № 3. P. 117–124.
54. Eschborn S., Weitkamp J.H. Procalcitonin versus C-reactive protein: review of kinetics and performance for diagnosis of neonatal sepsis // J. Perinatol. Springer US, 2019. Vol. 39, № 7. P. 893–903.
55. Chaudhuri PK, Ghosh A, Sinha V, Singh BK, Singh M, Lugova H, Ahmad R, Sinha S, Haque M K.S. The Role of C-reactive Protein Estimation in Determining the Duration of Antibiotic Therapy in Neonatal Sepsis. // Cureus. 2022. Vol. 14, № 10. P. e30211.
56. Ahmed E., Rehman A., Asghar Ali M. Validation of serum C-reactive protein for the diagnosis and monitoring of antibiotic therapy in neonatal sepsis // Pakistan J. Med. Sci. 2017. Vol. 33, № 6. P. 1434–1437.
57. Yochpaz S. et al. C-reactive protein in early-onset neonatal sepsis–a cutoff point for CRP value as a predictor of early-onset neonatal sepsis in term and late preterm infants early after birth? // J. Matern. Neonatal Med. Taylor & Francis, 2020. Vol. 0, № 0. P. 1–6.
58. Benitz WE, Han MY, Madan A R.P. Serial serum C-reactive protein levels in the diagnosis of neonatal infection. // Pediatrics. 1998. Vol. 102, № 4. P. E41.
59. Hincu M.A. et al. Relevance of biomarkers currently in use or research for practical diagnosis approach of neonatal early-onset sepsis // Children. 2020. Vol. 7, № 12.
60. Delanghe J.R., Speeckaert M.M. Translational research and biomarkers in neonatal sepsis // Clin. Chim. Acta. Elsevier B.V., 2015. Vol. 451. P. 46–64.
61. Hofer N. et al. An update on the use of C-reactive protein in early-Onset neonatal sepsis: Current insights and new tasks // Neonatology. 2012. Vol. 102, № 1. P. 25–36.
62. Mjelle AB, Guthe HJT, Reigstad H, Bjørke-Monsen AL M.T. Serum concentrations of C-reactive protein in healthy term-born Norwegian infants 48-72 hours after birth. // Acta Paediatr. 2019. Vol. 108, № 5. P. 849–854.
63. van Maldeghem I, Nusman CM V.D. Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis. // BMC Immunol. BMC Immunology, 2019. Vol. 20, № 1. P. 17.
64. Шарафутдинова Д. Р. , Балашова Е. Н., Сухова Ю. В., Кесслер Ю.А. [и др.]. Диагностическое значение пресепсина как маркера врожденного инфекционного процесса у новорожденных детей // Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2022. Vol. 21, № 1. P. 56–64.
65. Ruan L. et al. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: A meta-analysis and systematic review // Crit. Care. Critical Care, 2018. Vol. 22, № 1. P. 316.
66. Балашова Е.Н., Шарафутдинова Д.Р., Сухова Ю.В., Кесслер Ю.В., Титова К.Ю., Меньшикова А.А., Киртбая А.Р., Рындин А.Ю., Иванец Т.Ю., Ионов О.В. Д.Д.Н. Диагностическая точность пресепсина , прокальцитонина и С-реактивного белка у новорожденных с ранним неонатальным сепсисом : одноцентровое проспективное исследование // Неонатология: новости, мнения, обучение. 2023. Vol. 11, № 3. P. 10–21.